Volak, Adrienn
LeRoy, Stanley G.
Natasan, Jeya Shree
Park, David J.
Cheah, Pike See
Maus, Andreas
Fitzpatrick, Zachary
Hudry, Eloise
Pinkham, Kelsey
Gandhi, Sheetal
Hyman, Bradley T.
Mu, Dakai
GuhaSarkar, Dwijit
Stemmer-Rachamimov, Anat O.
Sena-Esteves, Miguel
Badr, Christian E.
Maguire, Casey A. http://orcid.org/0000-0001-8681-5179
Funding for this research was provided by:
Cure Alzheimer’s Fund
American Brain Tumor Association
National Cancer Institute (K22CA197053)
Article History
Received: 5 December 2017
Accepted: 28 March 2018
First Online: 16 May 2018
Compliance with ethical standards
:
: CAM has submitted patent applications regarding the exo-AAV platform. CAM holds equity in and is a founder and scientific advisor of Chameleon Biosciences, Inc, a gene therapy company.